0000919574-12-003490.txt : 20120515 0000919574-12-003490.hdr.sgml : 20120515 20120515132047 ACCESSION NUMBER: 0000919574-12-003490 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120331 FILED AS OF DATE: 20120515 DATE AS OF CHANGE: 20120515 EFFECTIVENESS DATE: 20120515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Broadfin Capital, LLC CENTRAL INDEX KEY: 0001511901 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-14251 FILM NUMBER: 12842880 BUSINESS ADDRESS: STREET 1: 237 PARK AVENUE, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212-808-2463 MAIL ADDRESS: STREET 1: 237 PARK AVENUE, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 13F-HR 1 d1284323_13f-hr.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F Cover Page Report for the Calendar Year or Quarter Ended: March 31, 2012 Check here if Amendment: |_|; Amendment Number: ____ This Amendment (Check only one): |_| is a restatement |_| adds new holding entries. Institutional Manager Filing this Report: Name: Broadfin Capital, LLC Address: 237 Park Avenue Ninth Floor New York, NY 10017 13F File Number: 028-14251 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Kevin Kotler Title: Managing Member Phone: (212) 808-2460 Signature, Place and Date of Signing: /s/ Kevin Kotler New York, New York May 15, 2012 ------------------- --------------------------- -------------------- [Signature] [City, State] [Date] Report Type: (Check only one): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report). [_] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting managers(s).) [_] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: None Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 1 Form 13F Information Table Entry Total: 34 Form 13F Information Table Value Total: $245,344 (thousands) List of Other Included Managers: Form 13F File Number Name (1) 028-14254 Broadfin Healthcare Master Fund, Ltd.

FORM 13F INFORMATION TABLE COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 TITLE VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY NAME OF ISSUER OF CLASS CUSIP (X$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE ALERE INC COM 01449J105 7,673 295,006 SH DEFINED 1 295,006 ALIGN TECHNOLOGY INC COM 016255101 5,812 210,951 SH DEFINED 1 210,951 ALKERMES PLC SHS G01767105 26,229 1,413,944 SH DEFINED 1 1,413,944 ALNYLAM PHARMACEUTICALS INC COM 02043Q107 6,432 581,018 SH DEFINED 1 581,018 AMARIN CORP PLC SPONS ADR NEW 023111206 10,256 906,025 SH DEFINED 1 906,025 ANACOR PHARMACEUTICALS INC COM 032420101 5,733 973,293 SH DEFINED 1 973,293 ANGIODYNAMICS INC COM 03475V101 13,475 1,100,000 SH DEFINED 1 1,100,000 ANTARES PHARMA INC COM 036642106 2,125 658,011 SH DEFINED 1 658,011 ARDEA BIOSCIENCES INC COM 03969P107 3,164 145,409 SH DEFINED 1 145,409 ATRICURE INC COM 04963C209 6,122 615,325 SH DEFINED 1 615,325 BOSTON SCIENTIFIC CORP COM 101137107 7,715 1,290,200 SH DEFINED 1 1,290,200 CAS MED SYS INC COM PAR $0.004 124769209 95 43,193 SH DEFINED 1 43,193 CONCEPTUS INC COM 206016107 3,516 244,502 SH DEFINED 1 244,502 COVIDIEN PLC SHS G2554F113 5,368 98,168 SH DEFINED 1 98,168 GIVEN IMAGING ORD SHS M52020100 2,323 124,006 SH DEFINED 1 124,006 INTELLIPHARMACEUTICS INTL IN COM 458173101 4,874 1,728,221 SH DEFINED 1 1,728,221 K V PHARMACEUTICAL CO CL A 482740206 1,452 1,100,000 SH DEFINED 1 1,100,000 LANNET INC COM 516012101 10,194 2,444,600 SH DEFINED 1 2,444,600 MEDICIS PHARMACEUTICAL CORP CL A NEW 584690309 7,274 193,499 SH DEFINED 1 193,499 MERIT MED SYS INC COM 589889104 11,322 911,570 SH DEFINED 1 911,570 NATUS MEDICAL INC DEL COM 639050103 18,287 1,532,837 SH DEFINED 1 1,532,837 NOVADAQ TECHNOLOGIES INC COM 66987G102 7,407 1,110,780 SH DEFINED 1 1,110,780 QLT INC COM 746927102 2,582 368,873 SH DEFINED 1 368,873 RIGEL PHARMACEUTICALS INC COM NEW 766559603 6,718 834,532 SH DEFINED 1 834,532 ROCKWELL MEDICAL TECH COM 774374102 103 10,900 SH DEFINED 1 10,900 SANOFI SPONSORED ADR 80105N105 6,047 156,045 SH DEFINED 1 156,045 SANTARUS INC COM 802817304 24,828 4,244,037 SH DEFINED 1 4,244,037 SOLTA MED INC COM 83438K103 7,639 2,521,036 SH DEFINED 1 2,521,036 ST JUDE MED INC COM 790849103 5,488 123,854 SH DEFINED 1 123,854 STRYKER CORP COM 863667101 2,774 50,000 SH DEFINED 1 50,000 TEVA PHARMACEUTICAL INDS LTD ADR 881624209 5,255 116,630 SH DEFINED 1 116,630 TRIUS THERAPEUTICS INC COM 89685K100 5,681 1,061,788 SH DEFINED 1 1,061,788 WATSON PHARMACEUTICALS INC COM 942683103 7,896 117,743 SH DEFINED 1 117,743 ZELTIQ AESTHETICS INC COM 98933Q108 3,487 565,200 SH DEFINED 1 565,200

SK 25125 0001 1284323